New study reveals novel multi-omics approach with unprecedented treatment response prediction in metastatic urothelial cancer

FHS
March 13, 2025
10:21 am

Novigenix, a leader in AI-driven healthcare solutions, has published a groundbreaking study showcasing the predictive power of its LITOSeek™ platform for immunotherapy response in metastatic urothelial cancer.

Vaccines safe for pregnant women with HIV but show reduced immune response

A meta-analysis in eClinicalMedicine finds vaccines are safe for pregnant women living with HIV, showing reduced immunogenicity compared to those without HIV but no increase

February 9, 2024

The beneficial effects of regular physical activity on the cardiovascular profile in the elderly

The effect of regular physical activity (PA) on the microcirculatory functions and plasma antioxidant capacity in older athletes.

October 20, 2023

Myogenes Clozapine Test promises to improve outcomes for schizophrenia patients

Myogenes, a leading innovator in genetic testing, has been awarded a grant from Innovate UK, the UK’s innovation agency, to further develop its revolutionary Myogenes

October 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.